Detailed answers about VIROCELL BIOLOGICS LTD, including incorporation, status, business activity, and accounts information.
When was VIROCELL BIOLOGICS LTD founded?
VIROCELL BIOLOGICS LTD was officially incorporated on 20 November 2020 and is registered under company number 13033264. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is VIROCELL BIOLOGICS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of VIROCELL BIOLOGICS LTD?
VIROCELL BIOLOGICS LTD's current status is In Administration. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does VIROCELL BIOLOGICS LTD do?
VIROCELL BIOLOGICS LTD operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is VIROCELL BIOLOGICS LTD's registered address?
The registered office address of VIROCELL BIOLOGICS LTD is FRP ADVISORY TRADING LTD, 110 CANNON STREET, LONDON, EC4N 6EU. This is the official address filed with Companies House for legal and statutory correspondence.
Is VIROCELL BIOLOGICS LTD financially stable?
The most recent accounts for VIROCELL BIOLOGICS LTD were made up to 31 December 2023, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2025.
Does VIROCELL BIOLOGICS LTD have any charges or mortgages?
VIROCELL BIOLOGICS LTD has 1 registered charge, of which 1 is outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.